HRAS and exocrine pancreatic carcinoma: In vitro treatment of tumor cells with a retroviral vector containing siRNA targeted at K-ras and H-ras mRNA caused a complete inhibition of pancreatic carcinoma growth and 80% inhibition of ovary tumors in mice [163, 164].